Linked e-resources
Details
Table of Contents
Intro
Preface
Contents
Chapter 1: Inflammation: Pathogenesis and Biological Markers
Introduction
Brief History and Definitions
Clinical Biomarkers
Immunology of Inflammation
Innate Immune System
Cells of the Innate Immune System
Molecular Components of the Innate Immune System
Adaptive Immune System
Components of Adaptive Immunity
Chronic Inflammation Associated with Adaptive Immunity
Anti-Inflammatory Therapy
Conclusions
References
Chapter 2: Obesity and Inflammation
Introduction
Obesity
Adipose Tissue
Introduction
Epidemiology and Risk Factors
Genetics
Inflammation, the Immune System, and Diabetes
The Role of Cytokines in the Development of Diabetes
Immune Checkpoint Inhibitor-Induced Diabetes
Treatment
Metformin
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Sodium-Glucose Co-Transporter 2 Inhibitors
Immune-Based Therapies
Systemic Inflammation and Diabetes
Conclusions
References
Chapter 4: Diabetes, Obesity, and Oxidative Stress
Introduction
Oxidative Stress
Obesity, Diabetes and Insulin Resistance
Key Molecular Mechanisms of Obesity, IR and DM Include Mitochondrial Dysfunction, ER Stress and ROS-Induced DNA Damage, which Are Closely Connected with the Major Cellular Disturbances Caused by OS
Mitochondrial Dysfunction
Endoplasmic Reticulum Stress
ROS-Induced DNA Damage
Conclusions
References
Chapter 5: Advanced Glycation End Products and Diabetes
Advanced Glycation End Products: Sources, Metabolism, Interaction with Receptors
Exogenous AGEs
Endogenous AGEs
Metabolism of AGEs
Interaction of AGEs with Receptors
Preface
Contents
Chapter 1: Inflammation: Pathogenesis and Biological Markers
Introduction
Brief History and Definitions
Clinical Biomarkers
Immunology of Inflammation
Innate Immune System
Cells of the Innate Immune System
Molecular Components of the Innate Immune System
Adaptive Immune System
Components of Adaptive Immunity
Chronic Inflammation Associated with Adaptive Immunity
Anti-Inflammatory Therapy
Conclusions
References
Chapter 2: Obesity and Inflammation
Introduction
Obesity
Adipose Tissue
Introduction
Epidemiology and Risk Factors
Genetics
Inflammation, the Immune System, and Diabetes
The Role of Cytokines in the Development of Diabetes
Immune Checkpoint Inhibitor-Induced Diabetes
Treatment
Metformin
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Sodium-Glucose Co-Transporter 2 Inhibitors
Immune-Based Therapies
Systemic Inflammation and Diabetes
Conclusions
References
Chapter 4: Diabetes, Obesity, and Oxidative Stress
Introduction
Oxidative Stress
Obesity, Diabetes and Insulin Resistance
Key Molecular Mechanisms of Obesity, IR and DM Include Mitochondrial Dysfunction, ER Stress and ROS-Induced DNA Damage, which Are Closely Connected with the Major Cellular Disturbances Caused by OS
Mitochondrial Dysfunction
Endoplasmic Reticulum Stress
ROS-Induced DNA Damage
Conclusions
References
Chapter 5: Advanced Glycation End Products and Diabetes
Advanced Glycation End Products: Sources, Metabolism, Interaction with Receptors
Exogenous AGEs
Endogenous AGEs
Metabolism of AGEs
Interaction of AGEs with Receptors